When it comes to stocks, 2021 was a year of great performance. However, among all of them, biotechnology companies have experienced the biggest growth. As the Covid-19 pandemic continues, pharmaceutical companies have been very appealing to investors. One of the companies whose shares reached the highest record is Moderna Inc.

Moderna has rallied over 168% and it’s definitely one of the best stocks of the year 2021. This is an easy conclusion given that Moderna was not generating revenue before it began selling vaccines. So, the rise and fall of its vaccine sales play a big role in the company’s stock price.

Investors influenced the stock increase after the release of Moderna’s high-efficacy mRNA coronavirus vaccine. Also, the company’s quick scale-up of production and distribution affected both its earnings and stock price.

However, August was very volatile for their stock price due to the diminishing number of Covid-19 cases. We saw it falling by almost 48% from highs of about $480 per share. But, at the same time, it still remained up by over 120% YTD.

Moderna’s financial performance has also been incredible, with the company sales going over $18 billion for 2021 (up 13 times more than the previous year). Plus, the average price per earnings (P/E) ratio in 2021 was 11.3.

In December 2021, Moderna was below 40% of its 52-weeks-high. However, this biotech leader had a 139.3% YTD stock return in 2021.

Booster shots that recently became recommended by CDC and WHO, helped Moderna get stronger again.

Investors who chose Moderna as their principal stock in 2021 ended the year with a profit. They also stand a very good chance for the upcoming period as many analysts believe Moderna will continue to be a top runner in the near future.